Equify Health founder and CEO Sylvie Leotin and Winship breast oncologist Keerthi Gogineni, MD will collaborate on a $750,000 grant to address cancer health disparities.
Emory University School of Medicine is collaborating with Equify Health on a $750,000 grant to address cancer health disparities.
The grant from Genentech, a leading biotechnology company, will fund equity-centered research with Black patients and oncology providers. Winship Cancer Institute of Emory University and Grady Memorial Hospital will serve as pilot sites for testing and implementation of Equify Health’s equity development training platform.
Equify Health was founded by Sylvie Leotin, a Black multicultural cancer survivor and tech innovator with extensive expertise in design and innovation. The company develops tools to empower health providers to understand the lived experience of patients of color and deliver empathic care.
"It's especially meaningful to me to work with Emory because of its commitment to health equity and prime location in Atlanta, an epicenter for Black lives in America. I cannot think of a better partner to pioneer solutions to improve the experience of Black patients with cancer, says Leotin."
Keerthi Gogineni, MD, assistant professor in the Department of Hematology and Medical Oncology at the Emory School of Medicine as well as a breast medical oncologist at Winship and Grady Memorial Hospitals, will be collaborating with Equify Health on the grant.
"Our goal is to improve the experience for Black patients with cancer and reduce disparities," says Gogineni. "This collaboration with Equify Health provides us, as oncology providers, with an incredible opportunity to build more empathetic relationships with Black patients and improve cancer care."
Anyone interested in learning more about this project should reach out here.
